New antibody approaches to lymphoma therapy

The CD20-directed monoclonal antibody rituximab established a new era in lymphoma therapy. Since then other epitopes on the lymphoma surface have been identified as potential targets for monoclonal antibodies (mAb). While most mAbs eliminate lymphoma cells mainly by antibody-dependent cellular cytot...

Descripción completa

Detalles Bibliográficos
Autores principales: Suresh, Tejas, Lee, Lisa X, Joshi, Jitesh, Barta, Stefan K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172963/
https://www.ncbi.nlm.nih.gov/pubmed/25355407
http://dx.doi.org/10.1186/s13045-014-0058-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172963/
https://www.ncbi.nlm.nih.gov/pubmed/25355407
http://dx.doi.org/10.1186/s13045-014-0058-4

Ejemplares similares